Company / CapEx per Share
Fulgent Genetics, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.73
FY2025
5-year range
$0.04 / $1.36
FY2021-FY2025
Trend
-46.2%
vs FY2024
Sector context
#76 of 148
Health Care
What the data says
At $0.73, Fulgent Genetics, Inc.'s capex per share ranks #76 of 148 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.04 in FY2016 to $1.64 in FY2020.
Based on SEC 10-K filings.
0.73 in FY2025 with a 5-year CAGR of -14.9%.
Declined from $0.81 to $0.73 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -14.3%
- 5-Year CAGR
- -14.9%
- 10-Year CAGR
- -
Sector benchmark
#76 of 148 in Health CareTop 51% of 148This company $0.73 Sector average $1.67
▼
-56.2% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 46.2% year-over-year.
- Ranks #76 out of 148 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.73 | -46.2% |
| FY2024 | $1.36 | +68.1% |
| FY2023 | $0.81 | -30.6% |
| FY2022 | $1.16 | +2676.8% |
| FY2021 | $0.04 | -97.4% |
| FY2020 | $1.64 | +1179.7% |
| FY2019 | $0.13 | -21.2% |
| FY2018 | $0.16 | -1.0% |
| FY2017 | $0.16 | +296.0% |
| FY2016 | $0.04 | -76.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026